WO2021011885A1 - Claudin18 antibodies and methods of treating cancer - Google Patents

International application published with international search report

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

US10314890B2 - Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer - Google Patents

WO2021198157A1 - Rna compositions targeting claudin-18.2 - Google Patents

WO2021198157A1 - Rna compositions targeting claudin-18.2 - Google Patents

WO2021238831A1 - Anti-cldn18.2 antibodies and diagnostic uses thereof - Google Patents

Frontiers Clinical and Recent Patents Applications of PD-1/PD-L1 Targeting Immunotherapy in Cancer Treatment—Current Progress, Strategy, and Future Perspective

WO2022063272A1 - Novel anti-claudin18 antibodies - Google Patents

WO2021025177A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

Frontiers New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness

WO2019242505A1 - Antibody targeting cldn18.2, bispecific antibody, adc, and car, and applications thereof - Google Patents